2020-02-05
Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6)
Publication
Publication
Osteoporosis International: with other metabolic bone diseases
The original version of this article, published on 26 November 2019 contained a mistake. An author’s name was misspelled. The correct author name reads as follows: Susana Perez-Gutthann. The original article has been corrected.
| Additional Metadata | |
|---|---|
| doi.org/10.1007/s00198-020-05314-2, hdl.handle.net/1765/124684 | |
| Osteoporosis International: with other metabolic bone diseases | |
| Organisation | Department of Medical Informatics |
|
Berencsi, K., Sami, A. (A.), Ali, M.S. (M. S.), Marinier, K. (K.), Deltour, N. (N.), Perez-Gutthann, S., … Prieto-Alhambra, D. (D.). (2020). Correction to: Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2019), 10.1007/s00198-019-05181-6). Osteoporosis International: with other metabolic bone diseases. doi:10.1007/s00198-020-05314-2 |
|